Femme et Homme
- | Pays :
- Bulgaria
- United States
- | Organes : -
- | Spécialités : -
Extrait
The primary purpose of this Phase 1b double-blind, randomized, placebo-controlled trial is to evaluate the safety, tolerability, pharmacokinetic (PK), and biological effect of MSC2364447C administered for 4 weeks in systemic lupus erythematosus subjects (SLE).
Critère d'inclusion
- Lupus Erythematosus, Systemic